Overview
No overview information available.
Indication
⑴作乳化剂和稳定剂：用本品制备的乳剂，乳粒小，一般在1μm以下，吸收率高，物理性质稳定，不宜分层，可热压蒸汽灭菌。 ⑵作增溶剂：本品可因表面活性剂形成胶团，增加多种难溶性药物的表观溶解度。 ⑶作吸收促进剂：一方面由于本品使肠蠕动变慢，药物在胃肠道滞留时间增长，吸收增加，从而提高口服制剂的生物利用度。另一方面，本品与皮肤相容性佳，增加皮肤通透性，可促进外用药剂的吸收。 ⑷作固体分散的载体：固体型号的产品可作为一些固体分散物的载体（如灰黄霉素、地高辛、洋地黄毒苷等）从而大大地提高这些药物的溶解度，促进这些药物的吸收。用量一般在2％～10％。 ⑸作乳膏剂、栓剂基质：固体型号的本品，可作基质使用，起到缓释与延效的作用。 ⑹作缓释材料：分子量大的固体产品，用作黏合剂、包衣材料，可使制剂达到缓释、控释的目的。用量5％～15％。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2005/06/03 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| COLOXYL INFANT DROPS poloxamer 100mg/mL oral liquid bottle (reformulation) | 124463 | Medicine | A | 12/21/2005 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.